- Collagen Solutions said it expected first-half revenue to increase by 14.4%, driven by ongoing momentum in its newly established tissue business.

The company said it had continued to execute on its customer product development milestones, having signed new development customers, which represented additional future contract manufacturing opportunities, once these products are approved and launched.

Four new customer contracts and 10 new customers were acquired in the half. The company was expected to announce its interim results for the six months to 30 September 2019 on Tuesday, 3 December 2019. At 10:17am: [LON:COS] Collagen Solutions Plc share price was +0.05p at 3.55p

Story provided by